ResearchMoz

Prefilled Syringes Market (Glass and Plastic) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-11-22
No. Of Pages » 74
 Prefilled syringes represent one of the fastest growing segments among the injectable drug delivery devices market. It is mainly due to the various advantages associated with the use of prefilled syringes such as ease of administration, reduced risk of cross contamination, less overfill and ease of handling. 
   
 The two major segments described in the study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.3.2 Models
1.3.3 Assumptions

Chapter 2 Executive Summary

Chapter 3 Global Prefilled Syringes Market Overview
3.1 Introduction to Prefilled Syringes
3.2 Prefilled Syringes: Manufacturers and Buyers
3.3 Prefilled Syringes: Manufacturing and Packaging Challenges
3.4 Market Dynamics
3.4.1 Market Drivers
3.4.1.1 Continuous growth in injectable drugs market
3.4.1.2 Benefits over traditional vial and syringe packaging systems
3.4.1.3 Rise in demand for point-of-care administration
3.4.1.4 Technological advancements in manufacturing of prefilled syringes
3.4.2 Market Restraints
3.4.2.1 Alternative drug delivery methods
3.4.2.2 Meeting standards set by regulatory authorities
3.4.3 Market Opportunities
3.4.3.1 Cost containment along with use superior material for syringe manufacturing
3.5 Porter’s Five Force Analysis: Global Prefilled Syringes Market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of substitutes
3.5.4 Threat of new entrants
3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis: Global Prefilled Syringes Market, by Geography

Chapter 4 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 – 2019
4.1 Overview
4.1.1 Global Prefilled Syringes Market Revenue, by Segment, 2011 – 2019 (USD Million)
4.1.2 Global Prefilled Syringes Market Volume, by Segment, 2011 – 2019 (Million Units)
4.2 Glass prefilled syringes
4.2.1 Global Glass Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
4.2.2 Global Glass Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
4.3 Plastic prefilled syringes
4.3.1 Global Plastic Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
4.3.2 Global Plastic Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)

Chapter 5 Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019
5.1 Overview
5.1.1 Global Prefilled Syringes Market Revenue, by Geography, 2011-2019 (USD Million)
5.1.2 Global Prefilled Syringes Market Volume, by Geography, 2011 - 2019 (Million Units)
5.1.3 Comparative Analysis: Global Prefilled Syringes Market, by Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Prefilled Syringes Market Revenue, 2011-2019 (USD Million)
5.2.2 North America Prefilled Syringes Market Volume, 2011-2019 (Million Units)
5.3 Europe
5.3.1 Europe Prefilled Syringes Market Revenue, 2011-2019 (USD Million)
5.3.2 Europe Prefilled Syringes Market Volume, 2011-2019 (Million Units)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Prefilled Syringes Market Revenue, 2011-2019 (USD Million)
5.4.2 Asia-Pacific Prefilled Syringes Market Volume, 2011-2019 (Million Units)
5.5 Rest of the World (Row)
5.5.1 Rest of the World (ROW) Prefilled Syringes Market Revenue, 2011-2019 (USD Million)
5.5.2 Rest of the World (ROW) Prefilled Syringes Market Volume, 2011-2019 (Million Units)

Chapter 6 Competitive Landscape
6.1 Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Adopting polymer technology to manufacture prefilled syringes
7.2 Investing in the rapidly growing market of North America, especially the U.S.
7.3 Mergers and acquisitions

Chapter 8 Company Profiles
8.1 Baxter International, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Becton, Dickinson & Company
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Bespak
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.4 Gerresheimer AG
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.5 Nipro Corporation
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.6 Schott AG
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.7 Stevanato Group
8.7.1 Company Overview
8.7.2 Product Portfolio
8.7.3 Business Strategies
8.8 Unilife Corporation
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Recent Developments
8.9 Vetter Pharma International GmbH
8.9.1 Company Overview
8.9.2 Product Portfolio
8.9.3 Business Strategies
8.9.4 Recent Developments
8.10 West Pharmaceutical Services, Inc.
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.11 Ypsomed Holding AG
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments

List of Tables


TABLE 1 Market Snapshot: Global Prefilled Syringes Market (2012 & 2019)
TABLE 2 Global Prefilled Syringe Market Revenue, by Segment, 2011 – 2019 (USD Million)
TABLE 3 Global Prefilled Syringe Market Volume, by Segment, 2011 – 2019 (Million Units)
TABLE 4 Global Prefilled Syringes Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 5 Global Prefilled Syringes Market Volume, by Geography, 2011 – 2019 (Million Units)

List of Figures


FIG. 1 Prefilled Syringes: Market Segmentation
FIG. 2 Global Prefilled Syringes Market:Glass vs Plastic, by Revenue (%) and Volume (%), 2012
FIG. 3 Global Prefilled Syringes Market Revenue, by Geography, 2012 (USD Million)
FIG. 4 Porter’s Five Force Analysis: Global Prefilled Syringes Market
FIG. 5 Market Attractiveness Analysis: Global Prefilled Syringes Market, by Geography (2012)
FIG. 6 Global Glass Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
FIG. 7 Global Glass Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
FIG. 8 Global Glass Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Glass Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
FIG. 10 Comparative Analysis: Global Prefilled Syringes Market, By Geography, 2012 & 2019 (Value %)
FIG. 11 North America Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 North America Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
FIG. 13 Europe Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Europe Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
FIG. 15 Asia-Pacific Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Asia-Pacific Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
FIG. 17 RoW Prefilled Syringes Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 RoW Prefilled Syringes Market Volume, 2011 – 2019 (Million Units)
FIG. 19 Prefilled Syringes: Market Share, by Key Players, 2012 (%)
FIG. 20 Baxter International, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 21 Becton, Dickinson & Company: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 22 Bespak: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 23 Gerresheimer AG: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 24 Nipro Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 25 Schott AG: Annual Revenue, 2011 – 2012 (USD Million)
FIG. 26 Unilife Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 West Pharmaceuticals, Services, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 28 Ypsomed Holding AG: Annual Revenue, 2010 – 2012 (USD Million)

Upcoming Reports:

Specialty Synthetic Fiber Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth And Forecast, 2013 - 2019
By - Transparency Market Research
Synthetic fibers are chemically processed artificial fibers manufactured by spinneret extrusion. They are synthesized polymers. The raw materials for the manufacture of synthetic fibers include petrochemicals among others. There are various types of synthetic fibers such as para aramids, meta aramids, carbon fiber, UHMW polyethylene and glass fiber.  UHMW polyethylene is used for ballistic protection. In addition, other fibers such as para and meta aramids are used in protective clothing. These fibers exhibit excellent durability, mechanical properties and thermal stability....
Biosimulation Market - Global Scenario, Trends, Industry Analysis, Size, Share And Forecast, 2011 - 2018
By - Transparency Market Research
Biosimulation is computer aided mathematical simulation of biological systems and processes. Biosimulation is used for model based calculation of biological systems. The global biosimulation market is expected to grow at a considerable rate from 2011 to 2018.The primary reason for the growth of biosimulation is the increasing use of pharmacodynamic and pharmacokinetic (PKPD) modeling in pre-clinical drug development. PKPD is the most widely used method in drug development.  Increasing importance of advanced techniques to reduce the drug development and discovery cost is the...
Poland: xylene market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the xylene market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the xylene market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Blackstone Invests $800 Million in Asian Oil-Based Energy Company
Jul 31, 2014  
Blackstone Energy Partners announced to invest $800 million in an Asian based energy company that is led by former industry executives.  Blackstone is popularly considered a part of the world’s largest administrator of alternatives to financial stocks and bonds. New York-based managing director, Angelo Acconcia of Blackstone Energy Partners said in an interview that Tamarind...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...